SPI1 and prostate cancer: Biologically and directionally consistent with these findings, in our analysis, the meta-analysis lead SNP rs3740688-T was associated with decreased autoimmune/autoinflammatory disease (Hashimoto’s thyroiditis) risk, increased SPI1 expression and increased prostate cancer risk.